Access to anti-retroviral drugs, female in Qatar
Qatar: Access to anti-retroviral drugs, female was 43.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Qatar, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Qatar recorded 43.0% for access to anti-retroviral drugs, female in 2024.
Compared with earlier readings it is down 4.4% on the previous year and down 56.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Qatar peaked at 98.0% in 2015 and was at its lowest, 0.0%, in 2000.
Qatar ranks 126th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Qatar, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2015 | 98.0% | — |
| 2016 | 97.0% | -1.0% |
| 2017 | 83.0% | -14.4% |
| 2018 | 76.0% | -8.4% |
| 2019 | 72.0% | -5.3% |
| 2020 | 62.0% | -13.9% |
| 2021 | 61.0% | -1.6% |
| 2022 | 54.0% | -11.5% |
| 2023 | 45.0% | -16.7% |
| 2024 | 43.0% | -4.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 7 |
| 2010s | 85.2% | 72.0% | 98.0% | 5 |
| 2020s | 53.0% | 43.0% | 62.0% | 5 |
Countries ranked near Qatar
- 123 North Macedonia 49.0% compare
- 124 Malta 47.0% compare
- 125 Egypt 46.0% compare
- 127 Syrian Arab Republic 41.0% compare
- 128 Madagascar 39.0% compare
- 129 Afghanistan 38.0% compare
More gender data for Qatar
- Child population (UN estimates and projections) 510.87 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.71 % change on previous year (2030)
- Population 2,823 (2030)
- Working-age population (UN estimates and projections) 2,823 (2030)
- Population (UN estimates and projections), annual growth rate 0.9268 % change on previous year (2030)
- Age population, age 00, female, interpolated 14,984 (2025)
- Age population, age 00, male, interpolated 15,440 (2025)
- Age population, age 01, female, interpolated 15,715 (2025)
- Age population, age 01, male, interpolated 15,894 (2025)
- Age population, age 02, female, interpolated 16,180 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Qatar?
- Access to anti-retroviral drugs, female in Qatar was 43.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Qatar?
- The highest recorded value was 98.0% in 2015.
- What is the lowest access to anti-retroviral drugs, female recorded in Qatar?
- The lowest recorded value was 0.0% in 2000.
- How does Qatar rank for access to anti-retroviral drugs, female?
- Qatar ranks 126th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Qatar?
- Over the last ten years it is down 56.1%. The long-run trend across the full record is volatile.
- Where does this Qatar data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.